Main news

                                    PRESS RELEASE OF THE CARDIOPROGRESS FOUNDATION

                  Main results of the XI International Forum

                     for Cardiology and Internal Medicine

Cancer Identified as a New Cardiovascular Risk Factor
Cancer Identified as a New Cardiovascular Risk Factor A history of cancer is an independent predictor of major cardiovascular events in patients undergoing coronary angioplasty. Cancer should be considered a new cardiovascular risk factor in primary and secondary prevention.


Management of arrhythmogenic right ventricular cardiomyopathy
Management of arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a disease characterised by fibrofatty replacement of the ventricular myocardium due to specific mutations, leading to ventricular arrhythmias and sudden cardiac death. Treating this condition can be challenging due to progressive fibrosis, phenotypic variations and small patient cohorts limiting the feasibility of conducting meaningful clinical trials.


Editorial Activity

cardiology book

American Heart Association (AHA) Scientific Sessions 2022
American Heart Association (AHA) Scientific Sessions 2022 AHA’s Scientific Sessions 2022 in hybrid mode took place on Nov. 5-7, 2022, at McCormick Place Convention Center in Chicago, IL.


ACC Calls for More Career Flexibility in Cardiology
ACC Calls for More Career Flexibility in Cardiology A new statement from the American College of Cardiology (ACC) is calling for a greater degree of career flexibility in the specialty to promote cardiologists' personal and professional well-being and preserve excellence in patient care.


American Heart Associated
American Heart Associated A new statement from the American College of Cardiology (ACC) is calling for a greater degree of career flexibility in the specialty to promote cardiologists' personal and professional well-being and preserve excellence in patient care.



Prof. Aronow's career path
Prof. Aronow's career path Dear colleagues! The Cardioprogress Foundation presents the excerpts from the memoirs of the International Journal of Heart and Vascular Diseases editorial board member Wilbert S. Aronov, a cardiologist, professor of medicine, member of the FACC, FAHA, FACP, FCCP, FASPC, AGSF, FGSA. Dr. Wilbert Solomon Aronow was born in New York City on October 30, 1931. His parents were Russian Jewish immigrants. His grandparents were rabbis in Russia. Doctor Aronov dedicated his professional career to medicine.


World Heart Day 2022 in Iloilo
World Heart Day 2022 in Iloilo Iloilo province made history for hosting this year’s World Heart Day. It was chosen by the World Health Organization (WHO) as pilot area for the celebration. As highlight of the event, the whole façade of the Iloilo provincial capitol was illuminated on Thursday night, Sept. 29. The ceremonial event was led by Gov. Arthur Defensor Jr.; Department of Health (DOH) undersecretaries Dr. Kenneth Ronquillo and Atty. Charade Grande; DOH Western Visayas regional director, Dr. Adriano Zubaan; and representatives from WHO, Resolve to Save Lives, and World Heart Federation.


Climate change and health inequity a deadly mix for the most vulnerable: World Heart Federation
Climate change and health inequity a deadly mix for the most vulnerable: World Heart Federation Geneva, 29 September 2022 - On World Heart Day, the World Heart Federation (WHF) is calling for urgent action on climate change and health inequity, with millions more lives now at risk from cardiovascular disease, which is still the world’s biggest killer.


New ESC Guidelines for Cutting CV Risk in Noncardiac Surgery
New ESC Guidelines for Cutting CV Risk in Noncardiac Surgery The European Society of Cardiology (ESC) guidelines on cardiovascular assessment and management of patients undergoing noncardiac surgery have seen extensive revision since the 2014 version. They still have the same aim — to prevent surgery-related bleeding complications, perioperative myocardial infarction/injury (PMI), stent thrombosis, acute heart failure, arrhythmias, pulmonary embolism, ischemic stroke, and cardiovascular (CV) death.